CellAdhere™ 层粘连蛋白-521

与 TeSR™ 维持培养基配合使用,用于维持人胚胎干细胞(ES)和诱导多能干细胞(iPS)的基质

产品号 #(选择产品)

产品号 #77003_C

与 TeSR™ 维持培养基配合使用,用于维持人胚胎干细胞(ES)和诱导多能干细胞(iPS)的基质

产品优势

  • 采用重组人源蛋白基质,减少实验中的可变因素
  • 传代时无需使用抗凋亡抑制剂
  • 可与任何TeSR™系列培养基一起使用以维持hPSCs
  • 搭配 eTeSR™ 进行单细胞传代时,提高单细胞的黏附率和存活率
  • 利用这种生理相关基质模拟干细胞微环境

总览



为了在下游应用中获得一致的细胞群体和可重复的结果,推荐将 CellAdhere™™Laminin-521与TeSR™维持培养基联合使用,为细胞维持提供成分确定的培养基质。层粘连蛋白521是由人多能干细胞(hPSCs)在胚胎内细胞团中表达和分泌的,因此可在体外构建具有生物学相关性的 hPSC 培养环境。CellAdhere™ Laminin-521可与eTeSR™(产品号# 100 - 1215)维持培养基联合使用进行单细胞传代。与其他基质相比,CellAdhere™ Laminin-521 能提高单细胞的黏附率和存活率,且在长期培养过程中无需添加抗凋亡抑制剂。常规 PSC 聚集体传代可配合使用温和细胞分离试剂(GCDR)产品号# 07174)或ReLeSR™(产品号# 05872),进行单细胞传代时可使用Accutase™(产品号# 07920)。

人ES和iPS细胞的单细胞传代可能会产生选择压力,从而引起遗传异常。如果采用单细胞传代,建议定期进行核型检测。

细胞类型
多能干细胞
 
种属

 
品牌
CellAdhere
 

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
77003, 200-0117
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
77003
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
200-0117
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Resources and Publications

Educational Materials (9)

Publications (9)

Rapid generation of purified human RPE from pluripotent stem cells using 2D cultures and lipoprotein uptake-based sorting F. Michelet et al. Stem cell research {\&} therapy 2020

Abstract

BACKGROUND: Despite increasing demand, current protocols for human pluripotent stem cell (hPSC)-derived retinal pigment epithelium (RPE) remain time, labor, and cost intensive. Additionally, absence of robust methods for selective RPE purification and removal of non-RPE cell impurities prevents upscaling of clinical quality RPE production. We aimed to address these challenges by developing a simplified hPSC-derived RPE production and purification system that yields high-quality RPE monolayers within 90 days. METHODS: Human pluripotent stem cells were differentiated into RPE using an innovative time and cost-effective protocol relying entirely on 2D cultures and minimal use of cytokines. Once RPE identity was obtained, cells were transferred onto permeable membranes to acquire mature RPE morphology. RPE differentiation was verified by electron microscopy, polarized VEGF expression, establishment of high transepithelial electrical resistance and photoreceptor phagocytosis assay. After 4 weeks on permeable membranes, RPE cell cultures were incubated with Dil-AcLDL (DiI-conjugated acetylated low-density lipoproteins) and subjected to fluorescence-activated cell sorting (FACS) for purification and subculture. RESULTS: Using our 2D cytokine scarce protocol, hPSC-derived functional RPE cells can be obtained within 2 months. Nevertheless, at this stage, most samples contain a percentage of non-RPE/early RPE progenitor cells that make them unsuitable for clinical application. We demonstrate that functional RPE cells express high levels of lipoprotein receptors and that this correlates with their ability to uptake lipoproteins. Combining photoreceptor uptake assay with lipoprotein uptake assay further confirms that only functional RPE cells uptake AcLDL. Incubation of mixed RPE/non-RPE cell cultures with fluorophore conjugated AcLDL and subsequent FACS-based isolation of labeled cells allows selective purification of mature functional RPE. When subcultured, DiI-AcLDL-labeled cells rapidly form pure homogenous high-quality RPE monolayers. CONCLUSIONS: Pure functional RPE monolayers can be derived from hPSC within 90 days using simplified 2D cultures in conjunction with our RPE PLUS protocol (RPE Purification by Lipoprotein Uptake-based Sorting). The simplicity of this protocol makes it scalable, and the rapidity of production and purification allows for high-quality RPE to be produced in a short span of time making them ideally suited for downstream clinical and in vitro applications.
WNT inhibition and increased FGF signaling promotes derivation of less heterogeneous primed human embryonic stem cells, compatible with differentiation J. Taelman et al. Stem Cells and Development 2019

Abstract

Human embryonic stem cells (hESCs) hold great value for future clinical applications. However, standard culture conditions maintain hESCs in a primed state, which bears heterogeneity in pluripotency and a tendency for spontaneous differentiation. To counter these drawbacks, primed hESCs have been converted to a naive state, but this has restricted the efficiency of existing directed differentiation protocols. In mouse, WNT inhibition by inhibitor of WNT production-2, together with a higher dose of fibroblast growth factor 2 (12 ng/mL) in DMEM/F12 basal medium (DhiFI), markedly improved derivation and maintenance of primed mouse epiblast stem cells. In this study, we show that DhiFI conditions similarly improved primed hESC traits, such as conferring a primed transcriptional signature with high levels of pluripotency markers and reduced levels of differentiation markers. When triggered to differentiate to neuronal and cardiac lineages, DhiFI hESCs and isogenic primed hESCs progressed similarly. Moreover, DhiFI conditions supported the derivation of hESC lines from a post-inner cell mass intermediate (PICMI). DhiFI-derived hESCs showed less spontaneous differentiation and expressed significantly lower levels of lineage-specific markers, compared to primed-derived lines from the same PICMI. Overall, DhiFI hESCs retained advantages of both primed and naive pluripotency and may ultimately represent a more favorable starting point for differentiation toward clinically desired cell types.
Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture K. A. Knouse et al. Cell 2018

Abstract

Much of our understanding of chromosome segregation is based on cell culture systems. Here, we examine the importance of the tissue environment for chromosome segregation by comparing chromosome segregation fidelity across several primary cell types in native and nonnative contexts. We discover that epithelial cells have increased chromosome missegregation outside of their native tissues. Using organoid culture systems, we show that tissue architecture, specifically integrin function, is required for accurate chromosome segregation. We find that tissue architecture enhances the correction of merotelic microtubule-kinetochore attachments, and this is especially important for maintaining chromosome stability in the polyploid liver. We propose that disruption of tissue architecture could underlie the widespread chromosome instability across epithelial cancers. Moreover, our findings highlight the extent to which extracellular context can influence intrinsic cellular processes and the limitations of cell culture systems for studying cells that naturally function within a tissue. Tissue architecture and integrin function are critical factors that support chromosome segregation fidelity in epithelial tissues.

更多信息

更多信息
Species Human
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT STEMCELL, REFER TO WWW.STEMCELL.COM/COMPLIANCE.
版权 © 2025 STEMCELL Technologies 技术有限公司。保留所有权利。